$44.37
-0.05%The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
Quality against peers; 50 is the peer median.
PM peer median: the typical company the value is compared with. The /100 is its score against those peers.